UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$419M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$215M |
| 4 |
TAL Education Group
TAL
|
+$202M |
| 5 |
Intuit
INTU
|
+$190M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.6B |
| 2 |
NetEase
NTES
|
+$237M |
| 3 |
Goldman Sachs
GS
|
+$159M |
| 4 |
Baidu
BIDU
|
+$112M |
| 5 |
IAC Inc
IAC
|
+$108M |
Sector Composition
| 1 | Technology | 24.44% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Y-mAbs Therapeutics
YMAB
$390M
| $643K | ﹤0.01% |
16,749
+1,000
| +6% | +$38.4K |
|
1977
Theravance Biopharma
TBPH
$693M
| $642K | ﹤0.01% |
43,428
| – | – |
|
1978
Great Lakes Dredge & Dock
GLDD
$825M
| $641K | ﹤0.01% |
67,371
+3,451
| +5% | +$32.8K |
|
1979
Carpenter Technology
CRS
$12.3B
| $640K | ﹤0.01% |
35,255
-5,923
| -14% | -$108K |
|
1980
Enterprise Financial Services Corp
EFSC
$2.27B
| $639K | ﹤0.01% |
23,439
-390
| -2% | -$10.6K |
|
|
BBT
1981
Beacon Financial Corporation
BBT
$2.21B
| $638K | ﹤0.01% |
63,150
+3,589
| +6% | +$36.3K |
|
|
MDP
1982
DELISTED
Meredith Corporation
MDP
| $638K | ﹤0.01% |
48,660
| – | – |
|
1983
Guess, Inc.
GES
$870M
| $637K | ﹤0.01% |
54,856
| – | – |
|
1984
BioXcel Therapeutics
BTAI
$56.8M
| $633K | ﹤0.01% |
913
+582
| +176% | +$404K |
|
1985
1-800-Flowers.com
FLWS
$331M
| $632K | ﹤0.01% |
25,341
+9,262
| +58% | +$231K |
|
1986
PetMed Express
PETS
$58.5M
| $631K | ﹤0.01% |
19,966
+2,227
| +13% | +$70.4K |
|
1987
Axcelis
ACLS
$2.68B
| $631K | ﹤0.01% |
28,669
+3,798
| +15% | +$83.6K |
|
1988
Seaboard Corp
SEB
$3.77B
| $630K | ﹤0.01% |
222
-57
| -20% | -$162K |
|
1989
National Beverage
FIZZ
$3.69B
| $627K | ﹤0.01% |
18,430
+1,222
| +7% | +$41.6K |
|
1990
GoPro
GPRO
$286M
| $627K | ﹤0.01% |
138,344
+4,472
| +3% | +$20.3K |
|
1991
German American Bancorp
GABC
$1.54B
| $627K | ﹤0.01% |
23,088
-1,291
| -5% | -$35K |
|
|
CONN
1992
DELISTED
Conn's Inc.
CONN
| $624K | ﹤0.01% |
59,000
| – | – |
|
1993
Columbus McKinnon
CMCO
$423M
| $621K | ﹤0.01% |
18,773
+9,726
| +108% | +$322K |
|
1994
Gossamer Bio
GOSS
$750M
| $620K | ﹤0.01% |
49,952
+6,900
| +16% | +$85.6K |
|
1995
Newmark Group
NMRK
$3.45B
| $616K | ﹤0.01% |
142,569
-1,389
| -1% | -$6K |
|
1996
CTS Corp
CTS
$1.24B
| $615K | ﹤0.01% |
27,927
+660
| +2% | +$14.5K |
|
1997
Mativ Holdings
MATV
$678M
| $614K | ﹤0.01% |
20,214
-2,599
| -11% | -$79K |
|
1998
Tactile Systems Technology
TCMD
$302M
| $614K | ﹤0.01% |
16,780
+2,724
| +19% | +$99.7K |
|
1999
Arcturus Therapeutics
ARCT
$490M
| $613K | ﹤0.01% |
14,300
+3,200
| +29% | +$137K |
|
2000
Inogen
INGN
$230M
| $610K | ﹤0.01% |
21,039
+3,385
| +19% | +$98.2K |
|